The Association for Molecular Pathology announced the publication of best practice recommendations for clinical laboratories developing and performing homologous recombination deficiency (HRD) testing ...

NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...

The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations for clinical laboratories ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Blood levels of a protein called neurofilament light chain rise significantly in MS patients up to a year before they have a ...

Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and ...

A faulty lab test report that triggers panic and emergency hospitalisation amounts to a deficiency in service, Delhi State ...

GoPath Diagnostics, a leading provider of molecular and digital pathology services, today announced the launch of DiabetesNow ...

More than 7 million people have Alzheimer’s disease here in the United States. Now, a new blood test may be able to help with ...

Dr. Bernick said the new blood test, which was just approved by the FDA, is for adults over the age of 55 who are showing signs of Alzheimer’s disease. Alzheimer’s is the most common cause for ...

The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio test is an accurate, minimally invasive, accessible measurement of pTau 217 and β-Amyloid 1-42 concentrations in plasma as a proxy for the ...